Detail Cantuman

No image available for this title

Text  

Stocley's Drug Interactions; A Source book of interactions, their mechanisms, clinical importance and management


This edition is the restructuring of the information resulting in the creation of 11 new chapters. This is to allow better representation of the ...

  • CodeCallNoLokasiKetersediaan
    01021060500150Tersedia
  • Perpustakaan
    Fakultas Farmasi
    Judul Seri
    -
    No. Panggil
    615.1-1 Bax S
    Penerbit Pharmaceutical Press : London.,
    Deskripsi Fisik
    Ed.7-Cet.1. vii, 1208 hal. Ilus. ; 28 cm Index. Hl
    Bahasa
    Indonesia
    ISBN/ISSN
    0-85369-624-1
    Klasifikasi
    615.1-1 Bax S
    Tipe Isi
    -
    Tipe Media
    -
    Tipe Pembawa
    -
    Edisi
    NULL
    Subyek
    Info Detil Spesifik
    -
    Pernyataan Tanggungjawab
  • This edition is the restructuring of the information resulting in the creation of 11 new chapters. This is to allow better representation of the cardiovascular and anti-infective drugs, by separating out the main therapeutic groups, and to allow the inclusion of new chapters covering growing therapeutic areas, such as lipid-regulating drugs. The first chapter is general considerations and outline survey of some basic interaction mechanism. Second chapter is ACE inhibitors and angiotensin II receptor antagonist. Third chapter is alcohol. Fourth chapter is alpha blocker. Fifth chapter analgesic and NSAIDs. Sixth chapter is anthelmintics, antifungals and antiprotozoals. Seventh chapter is antiarrhythmics. Eight chapter is antibacterials. Ninth chapter is anticholinesterases. Tenth chapter is anticoagulants. Eleventh chapter is anticonvulsants. Twelfth chapter is antidiabetics. Thirteenth chapter is antihistamines. Fourteenth chapter is antimigraine drugs. Fifteenth chapter is antineoplastics. Sixteenth chapter is antiparkinsonian and related drugs. Seventeenth chapter is antiplatelet drugs. Eighteenth chapter is antipsychotics, anxiolytics and hypnotics. Nineteenth chapter is antivirals. Twentieth chapter is beta-blockers. Twenty one chapter is calcium channel blockers. Twenty-two chapter is cardiovascular drugs, miscellaneous. Twenty-three chapter is digitalis glycosides. Twenty-four chapter is diuretics. Twenty-five chapter is gastrointestinal drugs. Twenty-six chapter is hormonal contraceptives and sex hormones. Twenty-seven chapter is immunosuppressants. Twenty-eigth chapter is lipid-regulating drugs. Twenty-nine is lithium. Thirtieth chapter is MAOIs. Thirty one chapter is neuromuscular blockers. Thirty two chapter is respiratory drugs. Thirty three chapter is sympathomimetics. Thirty four chapter is tricylic, SSRIs and related antidepressants. Thirty five chapter is miscellaneous drugs.
  • Tidak tersedia versi lain

  • Silakan login dahulu untuk melihat atau memberi komentar.


Informasi